Eubiotics Market Size
At USD 5 billion in 2022, eubiotics market size is expected to rise at around 6.5% CAGR from 2023 to 2032. motivated by the growing frequency of livestock diseases among the domesticated animals of today.
To get key market trends
Farmers all around the globe have been observing a concerning rise in cattle diseases in recent years. According to the World Health Organisation (WHO), about 200 different diseases can pass from animals to humans nowadays. This is also the reason we are witnessing increasing numbers of incidences of individuals contracting illnesses from animals. For instance, the US Centers for Disease Control and Prevention (CDC) approximates that infections originating from animals or their environs cause about 450,000 illnesses among Americans annually. Farmers are also growing more concerned about how to naturally stop these diseases given the current avian flu epidemic and rising issue of drug resistance.
Meanwhile, stiff competition among manufacturers of plant-based meat substitutes is also creating a high impetus for the adoption of superior quality animal feed.
| Report Attribute | Details |
|---|---|
| Base Year | 2022 |
| Eubiotics Market Size in 2022 | USD 5 Billion |
| Forecast Period | 2023 to 2032 |
| Forecast Period 2023 to 2032 CAGR | 6.9% |
| 2032 Value Projection | USD 9.5 Billion |
| Historical Data for | 2018 to 2022 |
| No. of Pages | 434 |
| Tables, Charts & Figures | 639 |
| Segments covered | Application, Form, Product, Livestock and Region |
| Growth Drivers |
|
| Pitfalls & Challenges |
|
What are the growth opportunities in this market?
Standardization challenges may hamper the eubiotics market demand
Functional feed components like eubiotics come into direct touch with the gastrointestinal system of an animal. Two main issues are the compatibility of these components with the gastrointestinal environment of the animal and their capacity to cause the intended effect on its health. Choosing eubiotics, particularly probiotics, and prebiotics for the cattle presents a further difficulty since users must consider numerous variables. Moreover, some antibiotics such rifaximin have the capacity to generate eubiotic alterations to the gut ecology, which can be a therapeutic benefit in some clinical environments, so hindering their adoption.
Eubiotics Market Analysis
Learn more about the key segments shaping this market
Based on application, the eubiotics market revenue from gut health segment is predicted to exceed USD 4 billion by 2032 on account of the rising R&D investments towards probiotic invention. The UK government committed over £200 million (USD 240 million) back in February 2022 to fight zoonotic diseases and improve veterinary capacity in the country. Concurrently, favorable policy improvements by food and drug watchdogs and growing acceptance of improved animal husbandry practices are improving the sector picture.
More commonly, producers find themselves paying outrageous treatment expenses for animals with intestinal illnesses. In this sense, eubiotics help to regulate the microbiome of animals, therefore enhancing gut condition. They lower coliums and diarrhea as well as change the microbiota in the gastrointestinal system.
Driven to the low storage and transportation costs associated, form dictates that the eubiotics market share from the dry form segment is expected to grow at 6.5% CAGR through 2032. While preserving cultural stability as well, dry eubiotics also guarantee lengthy shelf life of feed. The aforementioned elements and encouraging projects from different companies to remove hazards and prevent the collapse of the food chain help to explain the especially strong demand in developing countries.
The Asian Development Bank made over USD 10 million investments in Zenex Animal Health, a top Indian animal health company, back in December 2021 in order to assist it in boosting the manufacturing and distribution of high-quality animal healthcare goods and so lower the risk of cattle diseases in the area.
Learn more about the key segments shaping this market
The eubiotics market size from swine segment is poised to reach USD 720 million by 2032. Pigs are highly susceptible to livestock diseases, which makes them a high-risk investment for farmers. As such, pig farmers put more efforts into ensuring that their livestock lead a healthy life and improve the overall financial performance of the farm. Diseases such as classical swine fever, a highly contagious viral disease that affects pigs, and the infection caused by its less virulent isolates is hard to be examined in older pigs, which makes it pertinent that the animals have good immunity.
The dietary supplementation of probiotics helps improve gut health and nutrient digestibility to benefit the growth performance of pigs. Probiotics also impart diarrhea reduction and antitoxin effects, which favors their adoption.
Looking for region specific data?
The eubiotics market share from organic acid segment is estimated to observe around 4% growth rate during the forecast period, led by the product’s antimicrobial and preservative effects. Organic acid-based eubiotics also help enhance growth performance of animals and help achieve optimum gut health, making them highly preferred among farmers. The product helps manage the microflora in animals during stressful conditions as well, creating a strong impetus for segment growth. They further improve animal performance by reducing gastric pH while also enhancing pepsin activity.
On the regional front, the North America eubiotics market is predicted to exhibit a CAGR of 6% during 2023 to 2032, on account of increasing investments towards animal health in the region. Back in December 2021, the US Department of Agriculture’s (USDA) APHIS announced an investment of over USD 16.3 million in 64 projects geared towards animal health protection.
Meanwhile, regional growth can also be ascribed to favorable GRAS approval policies for eubiotics products. Rising consumption of dairy and meat-based food in the region, driven by improved economic scenarios and cost-effectiveness is further escalating the demand for eubiotics.
Eubiotics Market Share
Some of the leading companies involved in the eubiotics market include
- ROQUETTE Freres
- DSM
- BASF SE
- Cargill, Inc.
- Calpis Co., Ltd.
- Novus International
- Beneo GmbH
- Novozymes
Many of these companies are focusing on collaborations to reinforce their market position. For instance, in June 2020, DSM, a Dutch multinational health and nutrition company entered into a 10-year collaboration with North Carolina State University. This research partnership emphasizes three functional areas including precision nutrition, animal gut health, and data-driven decision-making for animal health.
This strategic move will help the company increase its market share, enhance its brand reputation, and diversify its product line.
Impact of the COVID-19 pandemic
The COVID-19 pandemic drastically affected the animal feed industry demand due to supply chain disruptions and closures. Due to the labor-intensive nature of this industry, prolonged lockdowns and constrained international transport severely hindered its ability to make money. However, spurred by the resumption of operations post-COVID-19 and favorable government support, the industry is recovering at a steady pace. In fact, back in September 2021, the USDA announced an investment of over USD 3 billion for animal health and nutrition, and agriculture, covering animal disease prevention as well.
This eubiotics market research report includes in-depth coverage of the industry with estimates & forecast in terms of volume in Kilo Tons, and revenue in USD Million from 2018 to 2032 for the following segments
Click here to Buy Section of this Report
Market Size, By Product
- Prebiotics
- Inulin
- FOS
- MOS
- GOS
- Probiotics
- Lactobacillus
- Bifidobacterium
- Bacillus
- Streptococcus
- Organic Acid
- Acetic Acid
- Lactic Acid
- Fumaric Acid
- Formic Acid
- Propionic Acid
- Essential Oil
- Exogeneous Enzymes
- Amylase
- Protease
- Phytase
- Xylanses
- ß- glucanase
Market Size, By Form
- Dry
- Liquid
Market Size, By Application
- Gut Health
- Yield
- Immunity
Market Size, By Livestock
- Poultry
- Swine
- Cattle
- Aquaculture
The above information has been provided for the following regions and countries
- North America
- U.S.
- Canada
- Mexico
- Europe
- Germany
- France
- UK
- Spain
- Italy
- Russia
- Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Malaysia
- Thailand
- Latin America
- Brazil
- Middle East & Africa
- Saudi Arabia
- UAE
- South Africa
Related Reports
FAQ'S
For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:
Within 24 to 48 hrs.
You can contact Sales team (sales@marketinsightsresearch.com) and they will direct you on email
You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.
Discounts are available.
Hard Copy